These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 4027482)

  • 1. The effects of dopexamine on the cardiovascular system of the dog.
    Brown RA; Farmer JB; Hall JC; Humphries RG; O'Connor SE; Smith GW
    Br J Pharmacol; 1985 Jul; 85(3):609-19. PubMed ID: 4027482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular actions of dopexamine in anaesthetized and conscious dogs.
    Einstein R; Abdul-Hussein N; Wong TW; Chang DH; Matthews R; Richardson DP
    Br J Pharmacol; 1994 Jan; 111(1):199-204. PubMed ID: 7912154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cardiovascular actions of dopexamine hydrochloride, an agonist at dopamine receptors and beta 2-adrenoceptors in the dog.
    Smith GW; Hall JC; Farmer JB; Simpson WT
    J Pharm Pharmacol; 1987 Aug; 39(8):636-41. PubMed ID: 2888855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arrhythmogenic potential of dopexamine hydrochloride during halothane anaesthesia in dogs.
    Neustein SM; Dimich I; Sampson I; Sadeghi A; Mezrow C; Shiang H
    Can J Anaesth; 1994 Jun; 41(6):542-6. PubMed ID: 7915210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in cardiovascular responsiveness to dopexamine and beta 1- and beta 2-adrenoceptor function after the chronic treatment of beta-adrenoceptor antagonists and agonists in anaesthetized dogs.
    Chang DH; Einstein R
    J Auton Pharmacol; 1996 Oct; 16(5):269-79. PubMed ID: 9023671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inotropic mechanisms of dopexamine hydrochloride in horses.
    Muir WW
    Am J Vet Res; 1992 Aug; 53(8):1343-6. PubMed ID: 1354950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors.
    Brown RA; Dixon J; Farmer JB; Hall JC; Humphries RG; Ince F; O'Connor SE; Simpson WT; Smith GW
    Br J Pharmacol; 1985 Jul; 85(3):599-608. PubMed ID: 2862944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular effects of dopexamine HCl in conscious and halothane-anaesthetised horses.
    Muir WW
    Equine Vet J Suppl; 1992 Feb; (11):24-9. PubMed ID: 9109955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular and renal haemodynamic effects of dopexamine: comparison with dopamine.
    Stephan H; Sonntag H; Henning H; Yoshimine K
    Br J Anaesth; 1990 Sep; 65(3):380-7. PubMed ID: 1977432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative systemic and regional hemodynamic effects of dopamine and dobutamine.
    Robie NW; Goldberg LI
    Am Heart J; 1975 Sep; 90(3):340-5. PubMed ID: 240265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the beta 2 adrenoceptor in mediating positive inotropic activity in the failing heart and its relation to the hemodynamic actions of dopexamine hydrochloride.
    Lang RM; Borow KM; Neumann A; Carroll JD; Weinert L; Murphy MB; Ghali J; Rajfer SI
    Am J Cardiol; 1988 Aug; 62(5):46C-52C. PubMed ID: 2841838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dopexamine: a new dopaminergic agonist].
    Perrin G; Papazian L; Martin C
    Ann Fr Anesth Reanim; 1993; 12(3):308-20. PubMed ID: 7902685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative significance of dopamine receptors, beta adrenoceptors and norepinephrine uptake inhibition in the cardiovascular actions of dopexamine hydrochloride.
    Goldberg LI; Bass AS
    Am J Cardiol; 1988 Aug; 62(5):37C-40C. PubMed ID: 2841837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular pharmacology of dopexamine in low output congestive heart failure.
    Leier CV; Binkley PF; Carpenter J; Randolph PH; Unverferth DV
    Am J Cardiol; 1988 Jul; 62(1):94-9. PubMed ID: 2898209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human renovascular effects of dopexamine hydrochloride: a novel agonist of peripheral dopamine and beta 2-adreno-receptors.
    Magrini F; Foulds R; Roberts N; Macchi G; Mondadori C; Zanchetti A
    Eur J Clin Pharmacol; 1987; 32(1):1-4. PubMed ID: 2884113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of effects of dopamine hydrochloride and dopexamine hydrochloride on abdominal and femoral hemodynamics in anesthetized dogs.
    van Kesteren RG; Heethaar RM; Charbon GA; Heethaar J; Brouwer FA
    Circ Shock; 1993 Jul; 40(3):227-33. PubMed ID: 8348685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the cardiovascular actions of dopamine and epinine in the dog.
    Itoh H; Kohli JD; Rajfer SI; Goldberg LI
    J Pharmacol Exp Ther; 1985 Apr; 233(1):87-93. PubMed ID: 2858584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the effects of dopexamine, a novel DA1 receptor and beta 2-adrenoceptor agonist, on cardiac function and splanchnic circulation in a canine model of hemorrhagic shock.
    Chintala MS; Moore RJ; Lokhandwala MF; Jandhyala BS
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar; 347(3):296-300. PubMed ID: 8097568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin infusion in conscious dogs. Effects on systemic and coronary hemodynamics, regional blood flows, and plasma catecholamines.
    Liang C; Doherty JU; Faillace R; Maekawa K; Arnold S; Gavras H; Hood WB
    J Clin Invest; 1982 Jun; 69(6):1321-36. PubMed ID: 6123523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic characterization of YM435, a novel dopamine DA1 receptor agonist, in anesthetized dogs.
    Yatsu T; Takizawa K; Kasai-Nakagawa C; Uchida W; Tanaka A; Asano M; Honda K; Takenaka T
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):382-8. PubMed ID: 9125677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.